At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Tablo Hemodialysis Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Multicenter, Open Label, Non-Randomized, Cross-Over Study Evaluating the Use of the Tablo Hemodialysis System In-Center and In-Home by Subjects With End Stage Renal Disease (ESRD) Who Are on Stable Dialysis Regimens
In Brief
A clinical study evaluating Tablo Hemodialysis System for End Stage Renal Disease. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the Tablo Hemodialysis System when used In-Center by trained individuals and In-Home by trained Subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnd Stage Renal Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 2015
Enrollment StartDec 2015
Primary CompletionMay 2019
TodayJul 2026
First PostedJun 2, 2015
Enrollment StartDec 1, 2015
Primary CompletionMay 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 11.1 years ago
Interventions
Tablo Hemodialysis Systemdevice